| Product dosage: 2mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.95 | $88.41 (0%) | 🛒 Add to cart |
| 60 | $2.53 | $176.81 $151.70 (14%) | 🛒 Add to cart |
| 90 | $2.39
Best per pill | $265.22 $214.99 (19%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
Tizanidine: Effective Muscle Spasticity Management - Evidence-Based Review
Tizanidine hydrochloride is a centrally acting alpha-2 adrenergic agonist that functions as a short-acting muscle relaxant. This synthetic compound bears structural resemblance to clonidine but exerts its primary therapeutic effects through selective binding to presynaptic and postsynaptic receptors in the spinal cord, effectively reducing spasticity by decreasing the release of excitatory neurotransmitters. Available in both immediate-release and extended-release formulations, tizanidine represents a cornerstone in the management of muscle spasticity across various neurological conditions.
baclofen
Baclofen represents one of those fascinating clinical tools that sits at the intersection of neurology, addiction medicine, and rehabilitation. When I first encountered this medication during my residency, it was primarily confined to the spasticity management protocols for spinal cord injury and multiple sclerosis patients. But over the past fifteen years, I’ve watched its therapeutic profile expand in ways that continue to surprise even seasoned clinicians. The journey really began when we started noticing unexpected benefits in our alcohol dependence patients who happened to be on baclofen for coincident spasticity.
ciplox
Ciprofloxacin, commonly encountered in clinical practice as Ciplox, represents a cornerstone fluoroquinolone antibiotic with a broad spectrum of activity against Gram-positive and Gram-negative bacteria. Its development marked a significant advancement in antimicrobial therapy, particularly for complex infections where other classes had begun to fail. We’ve relied on it for decades in hospital and community settings, but its use requires a nuanced understanding that only comes from seeing its effects—both intended and unintended—across hundreds of patient cases.
flexeril
Cyclobenzaprine is a centrally-acting muscle relaxant that’s been in clinical use for decades, yet remains widely misunderstood in its mechanisms and appropriate applications. When I first encountered this medication during my residency, the attending physician described it as “a sedative that happens to relax muscles” - an oversimplification that stuck with me through years of clinical practice. The reality, as I’ve come to understand through treating hundreds of patients and reviewing the literature, is far more nuanced.
Lioresal: Effective Spasticity Management for Neurological Disorders - Evidence-Based Review
Baclofen, marketed under the brand name Lioresal among others, is a medication primarily used to treat spasticity. It is a central nervous system (CNS) depressant and acts as a GABA-B receptor agonist, specifically targeting the spinal cord to reduce the severity and frequency of muscle spasms. This agent is a cornerstone in managing spastic movement disorders, particularly in conditions like multiple sclerosis, spinal cord injuries, and cerebral palsy. Its role extends beyond mere symptom relief; by modulating hyperactive reflexes, Lioresal can significantly improve mobility, reduce pain associated with muscle stiffness, and enhance overall quality of life for patients grappling with chronic spasticity.
robaxin
Robaxin, known generically as methocarbamol, is a centrally-acting skeletal muscle relaxant that’s been in clinical use for decades. It’s not a dietary supplement but rather a prescription medication in most countries, though its availability varies by jurisdiction. What makes Robaxin particularly interesting is its unique mechanism compared to other muscle relaxants - it doesn’t work directly on muscles but rather depresses polysynaptic reflexes in the central nervous system. I’ve been prescribing this medication since my residency in the late 1990s, and it’s fascinating how its clinical utility has evolved while the fundamental pharmacology remains the same.
Skelaxin: Targeted Muscle Relaxation with Reduced Sedation - Evidence-Based Review
Skelaxin, known generically as metaxalone, is a centrally-acting skeletal muscle relaxant with a distinct chemical structure (5-[(3,5-dimethylphenoxy)methyl]-2-oxazolidinone) that differentiates it from other agents in its class. Unlike many muscle relaxants that primarily exert sedative effects, metaxalone demonstrates selective action on polysynaptic pathways in the spinal cord and brainstem while having minimal impact on monosynaptic reflexes. This pharmacological profile creates a therapeutic window where muscle relaxation occurs without proportional central nervous system depression, though sedation remains a possible side effect.
zanaflex
Tizanidine, marketed under the brand name Zanaflex, represents a centrally acting alpha-2 adrenergic receptor agonist primarily indicated for the management of spasticity. This skeletal muscle relaxant has carved out a significant niche in neurological rehabilitation and pain management protocols since its FDA approval, offering an alternative to traditional antispasmodics like baclofen and diazepam. What makes tizanidine particularly interesting isn’t just its efficacy—which we’ll explore in depth—but its unique pharmacological profile that balances muscle relaxation with a generally favorable side effect spectrum when dosed appropriately.
a ret gel
A ret gel represents one of the most significant advances in topical retinoid therapy we’ve seen in years. Unlike traditional tretinoin creams that often cause significant irritation, this stabilized retinaldehyde formulation delivers comparable efficacy with markedly improved tolerability. The development team spent nearly three years perfecting the encapsulation technology that protects the retinaldehyde molecule from oxidation while ensuring controlled release into the epidermis. I remember our lead formulator, Dr. Chen, arguing passionately against adding the penetration enhancers that marketing kept pushing for – turned out she was absolutely right to prioritize stability over immediate absorption.